AI technology is transforming the Indian pharmaceutical landscape, particularly in enhancing compliance and supply chain transparency.
Annora Pharma, a subsidiary of Hetero Group, is collaborating with AltiusHub to upgrade its drug traceability system through AI-driven serialization and regulatory compliance technologies. This initiative aims to boost serialization efficiency by 45% and provide real-time visibility throughout its global supply chain, catering to major markets such as the US, EU, and ASEAN.
The new system will enable Annora Pharma to achieve complete visibility across all serialized products within three months, allowing for tracking from the packaging line to export. By replacing outdated serialization systems with a centralized platform, the company enhances its operational capabilities and regulatory reporting across multiple markets, while integrating seamlessly with its current packaging infrastructure.
This development reflects a significant shift in the pharmaceutical industry, moving towards unified, AI-enabled solutions that offer better data control and faster implementation. The deployment has already led to improved serialization processing and enhanced visibility in export operations, addressing the complexities of modern regulatory requirements. As Dr. Bhaskar Reddy of Hetero Group noted, the need for greater transparency and flexibility in data management is critical as supply chains evolve.
In summary, the partnership between Annora Pharma and AltiusHub exemplifies the growing trend of adopting AI technologies in pharma, enabling faster, more efficient compliance and traceability solutions that meet stringent global standards. This evolution not only streamlines operations but also positions companies to better navigate regulatory challenges in an increasingly complex market.